Hong Kong Investment Corporation Limited fully supports Hong Kong’s First Five-Year Plan and the Chief Executive’s 2026 Policy Address (September 2026)
(Hong Kong, 16th September) The Hong Kong Investment Corporation Limited (“HKIC”) fully supports the First Five-Year Plan for Economic and Social Development of the Hong Kong Special Administrative Region (2026-2030) (“Hong Kong’s First Five-Year Plan”) announced by the Chief Executive, and the Chief Executive’s 2026 Policy Address (“Policy Address”) subsequently delivered. The HKIC believes that the two documents fully demonstrate the HKSAR Government’s resolve to take a long-term view in charting Hong Kong’s future development and proactively align with the National 15th Five-Year Plan. They will lay an even stronger foundation for high-quality economic and social development in Hong Kong, continuously improve the well-being of citizens, and enable Hong Kong to make unique and more substantial contributions to national development.
Hong Kong’s First Five-Year Plan upholds the important principle of bringing together an “effective market” and a “capable government”. This will leverage the Government’s strategic guidance, stimulate innovation and vitality among enterprises, guide the efficient allocation of capital, talent, technology and other key factors, and create a synergised impetus driving the high-quality development of Hong Kong. Hong Kong’s First Five-Year Plan explicitly states that the Government will use the HKIC, which it wholly owns, as Patient Capital to actively pursue co-investments focusing on Hard and Core Technology, Biotechnology, New Energy and Green Technology, and related applications, and advance the “Finance +” strategy. The Plan also seeks to channel market capital towards strategic emerging industries such as semiconductors, artificial intelligence (“AI”) and robotics, life and health technology, and new energy and new materials, foster New Quality Productive Forces, and invest in frontier fields to make forward-looking preparations for future industries. These directions are closely aligned with the investment focus and layout of the HKIC since its establishment, underscoring the strategic foresight of the HKIC and the value of its forward-looking positioning in key areas.
Ms Clara Chan, Chief Executive Officer of the HKIC, said, “The HKIC puts the closer integration of an ‘effective market’ and a ‘capable government’ into practice. We leverage the Patient Capital to provide strategic guidance, while investing with a market-oriented, professional and international approach and growing together with market partners to share the rewards. The HKIC will continue to strategically connect capital, industry, innovation and technology (“I&T”) and talent, turning the country’s needs and Hong Kong’s strengths into growth momentum.”
Ms Chan added, “The clear positioning of the HKIC in Hong Kong’s First Five-Year Plan and the Policy Address affirms the important role of Patient Capital in developing Hong Kong’s I&T and strategic industries, and gives us even greater impetus. The ultimate purpose of economic development is to enable citizens to share the fruits of development and enhance their sense of happiness and quality of life. We will continue to play our role in investment leadership and capital curation, support emerging and future industries, and help Hong Kong better integrate into and serve overall national development.”
Since its establishment, the HKIC has invested in over 200 projects, with its early initiatives closely aligned with the key priorities of the Policy Address. These include investing in companies specialising in large AI models and embodied intelligence; investing in leading RISC-V enterprises and spearheading the establishment of the Hong Kong RISC-V Alliance to advance open-source chips R&D and industrialisation; supporting the development of biotech and health technology and surgical robotics; investing in local aerospace technology start-ups to make forward-looking deployments in commercial aerospace and the space economy; supporting the development of a sustainable aviation fuel value chain in the Guangdong-Hong Kong-Macao Greater Bay Area through its portfolio companies; and establishing the world’s first offshore renminbi venture capital fund with a focus on frontier technology, which not only supports national tech enterprises in going global, but also helps strengthen Hong Kong’s role as the world’s largest offshore renminbi business hub. In addition, the HKIC is making strategic investments to deploy capital in repurposing existing resources to support Hong Kong’s education and talent development as an international education hub, and establish Hong Kong as an international hub for high-calibre talent.
Currently, every Hong Kong dollar invested by the HKIC has attracted over 8 Hong Kong dollars from international long-term market capital, creating a “capital multiplier” effect that fully demonstrates the strategic value of the HKIC’s “Patient Capital” and “Investment +” strategy in developing Hong Kong’s future industries. Furthermore, with the HKIC’s support, approximately 70% of its portfolio companies have launched or are expanding their operations overseas, including in Belt and Road countries.
The HKIC will also actively support the objectives of Hong Kong’s First Five-Year Plan and the Policy Address to accelerate the development of the Northern Metropolis. Building on the positioning of the Northern Metropolis as the key growth engine for post-secondary education and I&T development, the HKIC will channel market resources to support portfolio companies in establishing a presence there, promote the synergised development of industrial parks, universities and research institutions, and foster an innovation ecosystem where industry, academia and research are integrated. The HKIC will also continue to strengthen its role in connecting with Chinese Mainland and bringing in global resources, make good use of major cooperation platforms in the Guangdong-Hong Kong-Macao Greater Bay Area, including Qianhai, Nansha and Hetao, facilitate the cross-boundary flow of innovation factors, transformation of R&D outcomes and industrial chain collaboration, and help Hong Kong better perform its roles as a “super connector” and a “super value-adder”.
The HKIC will work alongside all sectors of the community to translate the development blueprint of Hong Kong’s First Five-Year Plan and the key measures in the Policy Address into tangible outcomes that foster a more vibrant economy, a better society, and a happier life for citizens in Hong Kong.
– END –
About HKIC
The HKIC was established in 2022 as the Patient Capital institution wholly owned by and representing the HKSAR Government. It adopts an “Investment +” approach, seeking reasonable financial return in the medium to long term and at the same time creating and supporting the growth impetus with a view to contributing to Hong Kong’s economy and society.
The HKIC currently manages the “Hong Kong Growth Portfolio”, “Greater Bay Area Investment Fund”, “Strategic Tech Fund”, and “Co-Investment Fund”. At this stage, it is focusing on three key sectors, namely Hard and Core Technology, Biotechnology and Health Technology, and New Energy and Green Technology, as well as the relevant applications. Currently, the HKIC has invested in over 200 projects. Every Hong Kong dollar invested by the HKIC has attracted over 8 Hong Kong dollars from long-term market capital for investment.